Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Kidney renal papillary cell carcinoma (KIRP) has a high mortality rate and a poor prognosis. Cu concentrations differed significantly between renal cancer tissues and adjacent normal tissues. Cuproptosis is a newly identified cell death. Long non-coding RNAs (lncRNAs) play a crucial role in the prog...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Tongjin Xie, Bin Liu, Dongbo Liu, Yusong Zhou, Qingping Yang, Dai Wang, Mengjie Tang, Wei Liu
Format:	Artykuł
Język:	English
Wydane:	Frontiers Media S.A. 2022-12-01
Seria:	Frontiers in Pharmacology
Hasła przedmiotowe:	lncRNA cuproptosis KIRP prognosis immune relevance
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1103986/full

Podobne zapisy

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
od: Yuchen Bai, i wsp.
Wydane: (2022-11-01)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
od: Mingyi Yang, i wsp.
Wydane: (2022-07-01)

Ferroptosis-Related lncRNA to Predict the Clinical Outcomes and Molecular Characteristics of Kidney Renal Papillary Cell Carcinoma
od: Yubo Gong, i wsp.
Wydane: (2024-02-01)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
od: Binfeng Liu, i wsp.
Wydane: (2022-10-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
od: Jingyi Wu, i wsp.
Wydane: (2023-09-01)

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
od: Ziwei Gao, i wsp.
Wydane: (2025-01-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
od: Pengpeng Zhang, i wsp.
Wydane: (2023-01-01)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
od: Yifan Xu, i wsp.
Wydane: (2022-10-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
od: Youlong Huili, i wsp.
Wydane: (2022-08-01)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
od: Xiaojing Yang, i wsp.
Wydane: (2022-09-01)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
od: Jia Chen, i wsp.
Wydane: (2022-12-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
od: Zhixun Bai, i wsp.
Wydane: (2022-12-01)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
od: Zi-Rong Jiang, i wsp.
Wydane: (2022-09-01)

Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer
od: Xinhai Sun, i wsp.
Wydane: (2024-05-01)

Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
od: Min Zhou, i wsp.
Wydane: (2024-11-01)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
od: Zheng Zhou, i wsp.
Wydane: (2023-03-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
od: Yue Wang, i wsp.
Wydane: (2022-09-01)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
od: Shusheng Zhu, i wsp.
Wydane: (2023-07-01)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
od: Binfeng Liu, i wsp.
Wydane: (2022-12-01)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
od: Chun Li, i wsp.
Wydane: (2023-07-01)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
od: Yidong Zhu, i wsp.
Wydane: (2023-02-01)

Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma
od: Xiaoping Wang, i wsp.
Wydane: (2023-02-01)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
od: Jun Wen, i wsp.
Wydane: (2023-01-01)

Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma
od: Xiaoran Bai, i wsp.
Wydane: (2024-06-01)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
od: Miaorong Xu, i wsp.
Wydane: (2022-07-01)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
od: Xinyu Liu, i wsp.
Wydane: (2022-09-01)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
od: Hui Chen, i wsp.
Wydane: (2023-01-01)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
od: Xiajing Liu, i wsp.
Wydane: (2022-11-01)

Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
od: Li Liu, i wsp.
Wydane: (2023-01-01)

Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs
od: Mingwei Wei, i wsp.
Wydane: (2024-04-01)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
od: Chao Ma, i wsp.
Wydane: (2023-02-01)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
od: Shengxian Xu, i wsp.
Wydane: (2022-07-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
od: Chong Li, i wsp.
Wydane: (2023-06-01)

Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
od: Hong-Fei Yao, i wsp.
Wydane: (2024-01-01)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
od: Junlin Shen, i wsp.
Wydane: (2023-08-01)

Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
od: Bohan Li, i wsp.
Wydane: (2023-12-01)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
od: Lin Pang, i wsp.
Wydane: (2023-03-01)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
od: Binxiang Chu, i wsp.
Wydane: (2022-12-01)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
od: Lei Ren, i wsp.
Wydane: (2023-02-01)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
od: Mengzhe Zhang, i wsp.
Wydane: (2023-09-01)